Indications and uses
relieves occasional constipation (irregularity) generally produces bowel movement in 12 to 72 hours
relieves occasional constipation (irregularity) generally produces bowel movement in 12 to 72 hours
adults and children 12 years and over take 1 - 3 softgels once daily or in divded doses children 2 to under 12 years of age 1 softgel once daily children under 2 years ask a doctor
Docusate sodium 100 mg
Stool softener laxative
Do not use if you are presently taking mineral oil, unless directed to do so by a doctor
Ask a doctor before use if you have
Ask a doctor or pharmacist before use if you are taking any other drug. Take this product two or more hours before or after other drugs. Laxatives may affect how other drugs work.
Stop use and ask a doctor if
These could be sings of a serious condition.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
| adults and children 12 years and over | take 1 - 3 softgels once daily or in divded doses |
| children 2 to under 12 years of age | 1 softgel once daily |
| children under 2 years | ask a doctor |
FD&C red #40, FD&C yellow #6, gelatin, glycerin, polyethylene glycol 400 NF, purified water, sorbitol
Call 516-341-0666 8:30 am - 4:30 pm ET, Monday - Friday
TAMPER EVIDENT: DO NOT USE IF IMPRINTED SEAL UNDER CAP IS BROKEN OR MISSING.
Repackaged and Distributed By:
Remedy Repack, Inc.
625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762
Docusate Sodium 100 mg Tablets, Red, Oval, Imprint: SCU1 supplied in:
NDC: 70518-2661-00
NDC: 70518-2661-01
PACKAGING: 28 in 1 BLISTER PACK
PACKAGING: 30 in 1 BLISTER PACK
Repackaged and Distributed By:
Remedy Repack, Inc.
625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762
DRUG: Docusate Sodium
GENERIC: Docusate Sodium
DOSAGE: CAPSULE
ADMINSTRATION: ORAL
NDC: 70518-2661-0
NDC: 70518-2661-1
COLOR: red
SHAPE: OVAL
SCORE: No score
SIZE: 13 mm
IMPRINT: SCU1
PACKAGING: 28 in 1 BLISTER PACK
PACKAGING: 30 in 1 BLISTER PACK
ACTIVE INGREDIENT(S):
INACTIVE INGREDIENT(S):
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 70518-2661-0 | 2023-10-16 | C162847 | 48780-1 | f386c649-e1da-0266-e053-dadaa90a7c1a | Docusate Sodium 100 mg |
| 70518-2661-1 | 2023-10-16 | C162847 | 48780-1 | f386c649-e1da-0266-e053-dadaa90a7c1a | Docusate Sodium 100 mg |
| 70518-2661-0 | 2023-01-30 | C162847 | 48780-1 | f386c649-e1da-0266-e053-dadaa90a7c1a | Docusate Sodium 100 mg |
| 70518-2661-1 | 2023-01-30 | C162847 | 48780-1 | f386c649-e1da-0266-e053-dadaa90a7c1a | Docusate Sodium 100 mg |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 69618-044-01 | EA - Each | 69618-044 | 5b004dec-1b24-4e29-89ef-d73df6f24794 | 1 | 2017-12-14 |
| 69618-044-10 | EA - Each | 69618-044 | f28ec5a7-79ec-485d-b308-0d36c8d3e13c | 1 | 2017-12-14 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 70518-2661 | 70518-2661-0, 70518-2661-1 |
| 69618-044 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| WATER | 059QF0KO0R | IACT |
| SORBITOL | 506T60A25R | IACT |
| POLYETHYLENE GLYCOL 400 | B697894SGQ | IACT |
| FD&C RED NO. 40 | WZB9127XOA | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| FD&C YELLOW NO. 6 | H77VEI93A8 | IACT |
| GELATIN | 2G86QN327L | IACT |
| DOCUSATE SODIUM | F05Q2T2JA0 | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| f6c88d87-66a6-2962-e053-6294a90acfbe | 224a671e-2c97-46fb-81d8-3c2fafe2aaa5 | 2023-03-13 | Warnings | 224a671e-2c97-46fb-81d8-3c2fafe2aaa5 |
Adverse event summaries are temporarily unavailable. Other product information remains available.